Results 211 to 220 of about 153,227 (272)

Efficacy of Tissue Tolerable Plasma (TTP) against Ixodes ricinus

, 2014
Claudia Bender, Axel Krämer
openalex   +2 more sources

Temporal trends in progression risk in smoldering myeloma: a systematic review. [PDF]

EClinicalMedicine
Ludwig H, Kastritis E, Bernhard S, van de Donk NWCJ, Boccadoro M, Terpos E, Musto P, Sonneveld P, Mohyuddin GR.   +8 more
europepmc   +1 more source

India: TTP – TiO2

Focus on Pigments, 2010
openaire   +1 more source

Malignant Hypertension-Induced Thrombotic Microangiopathy Mimicking Atypical Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. [PDF]

JACC Case Rep
Valdez-Thomas M, Carrasquel-Alvarez M, Acosta MDP, Hurtado-Leon YJ, Quintanilla MS, Khanal S.   +5 more
europepmc   +1 more source

Validation of plasmin-cleaved VWF as a biomarker for microthrombosis in Japanese patients with acute immune-mediated TTP. [PDF]

Blood Vessel Thromb Hemost
El Otmani H, Tersteeg C, Vanhoorelbeke K, Matsumoto M, Sakai K.   +4 more
europepmc   +1 more source

Update – PROFILE: Early‐Stage Researchers Advancing Insights on TTP through a Unique PhD Track

, 2019
Karen Vanhoorelbeke, Johana Hrdinová, Bogac Ercig, Chris Reutelingsperger, Jan Voorberg, Gerry A. F. Nicolaes   +5 more
openalex   +1 more source

Early-phase semi-quantitative analysis versus full time-course quantitative modeling of ultrafast dynamic contrast-enhanced MRI for breast cancer diagnosis, molecular subtyping, and treatment response prediction. [PDF]

Insights Imaging
Cao Y, Gong X, Huang Y, Chen H, Fang J, Wang L, Li L, Tang S, Yin T, Wang X, Zhang J.   +10 more
europepmc   +1 more source

TTP - Chapitre I.

, 1998
openaire   +2 more sources

Clinical characteristics and treatment response of patients with SLE complicated with thrombotic thrombocytopenic purpura. [PDF]

Lupus Sci Med
Zhang K, Zhao P, Huang B, Wang Y, Bi T, Gao P, Wang C, Xing X, Wang N, Feng R, Cheng G, Yao H, An Y, Zhou Y, Jin Y, Li Y, Li Z, He J.   +17 more
europepmc   +1 more source

A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial. [PDF]

Signal Transduct Target Ther
Chu N, Nie W, Du J, Wang M, Ma L, Wang Q, Wang J, Hu X, Wu J, Lu Y, Huang M, Wei Y, Wang Z, He JQ, Ding Z, Wei X.   +15 more
europepmc   +1 more source